These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10406190)

  • 1. Evidence against a role for endotoxin in the hyperdynamic circulation of rats with prehepatic portal hypertension.
    Chu CJ; Lee FY; Wang SS; Chang FY; Lin HC; Lu RH; Wu SL; Chan CC; Tai CC; Lai IN; Lee SD
    J Hepatol; 1999 Jun; 30(6):1105-11. PubMed ID: 10406190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperdynamic circulation in prehepatic portal hypertension: role of tumor necrosis factor-alpha.
    Chu CJ; Lee FY; Chang FY; Wang SS; Lin HC; Wu SL; Tai CC; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Mar; 59(3):145-50. PubMed ID: 9198288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminoguanidine corrects hyperdynamic circulation without ameliorating portal hypertension and portal hypertensive gastropathy in anesthetized portal hypertensive rats.
    Lee FY; Wang SS; Tsai YT; Lin HJ; Lin HC; Chu CJ; Wu SL; Tai CC; Lee SD
    J Hepatol; 1997 Mar; 26(3):687-93. PubMed ID: 9075678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor alpha: a major contributor to the hyperdynamic circulation in prehepatic portal-hypertensive rats.
    Lopez-Talavera JC; Merrill WW; Groszmann RJ
    Gastroenterology; 1995 Mar; 108(3):761-7. PubMed ID: 7875478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalidomide inhibits tumor necrosis factor alpha, decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats.
    Lopez-Talavera JC; Cadelina G; Olchowski J; Merrill W; Groszmann RJ
    Hepatology; 1996 Jun; 23(6):1616-21. PubMed ID: 8675185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endotoxin and the hyperdynamic circulation of portal vein-ligated rats.
    Mehta R; Gottstein J; Zeller WP; Lichtenberg R; Blei AT
    Hepatology; 1990 Nov; 12(5):1152-6. PubMed ID: 2227813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperdynamic circulation of cirrhotic rats with ascites: role of endotoxin, tumour necrosis factor-alpha and nitric oxide.
    Chu CJ; Lee FY; Wang SS; Lu RH; Tsai YT; Lin HC; Hou MC; Chan CC; Lee SD
    Clin Sci (Lond); 1997 Sep; 93(3):219-25. PubMed ID: 9337636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence against a role for endotoxin in the hepatic encephalopathy of rats with thioacetamide-induced fulminant hepatic failure.
    Chen CT; Chu CJ; Wang TF; Lu RH; Lee FY; Chang FY; Lin HC; Chan CC; Wang SS; Huang HC; Lee SD
    J Gastroenterol Hepatol; 2005 Mar; 20(3):450-5. PubMed ID: 15740491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats.
    Fernández M; García-Pagán JC; Casadevall M; Bernadich C; Piera C; Whittle BJ; Piqué JM; Bosch J; Rodés J
    Gastroenterology; 1995 May; 108(5):1487-95. PubMed ID: 7537235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of tumor necrosis factor, endothelin and nitric oxide on hyperdynamic circulation of rats with acute and chronic portal hypertension.
    Wang JJ; Gao GW; Gao RZ; Liu CA; Ding X; Yao ZX
    World J Gastroenterol; 2004 Mar; 10(5):689-93. PubMed ID: 14991939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic studies and esophageal morphometric analyses in portal hypertensive rats with left adrenal vein ligation.
    Lee FY; Wang SS; Tsai YT; Chang FY; Lin HC; Hou MC; Chu CJ; Wu SL; Tai CC; Lee SD
    Scand J Gastroenterol; 1997 Jul; 32(7):725-30. PubMed ID: 9246715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of nitric oxide in hyperdynamic circulation in portal hypertensive rats].
    Wu Z; Zhou J; Chen Z; Zhou H; Jiao Z; Kuang Y; Yuan J; Wang Q; Zeng M
    Zhonghua Wai Ke Za Zhi; 1998 Mar; 36(3):182-6. PubMed ID: 11825365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventive effect of preoperative portal vein ligation on endotoxin-induced hepatic failure in hepatectomized rats is associated with reduced tumour necrosis factor alpha production.
    Yachida S; Ikeda K; Kaneda K; Goda F; Maeba T; Maeta H
    Br J Surg; 2000 Oct; 87(10):1382-90. PubMed ID: 11044165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.
    Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW
    Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension.
    Cao H; Xu J; Liu H; Meng FB; Qiu JF; Wu ZY
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Na restriction blunts expansion of plasma volume and ameliorates hyperdynamic circulation in portal hypertension.
    Genecin P; Polio J; Groszmann RJ
    Am J Physiol; 1990 Sep; 259(3 Pt 1):G498-503. PubMed ID: 2399990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension.
    Xu J; Cao H; Liu H; Wu ZY
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):503-8. PubMed ID: 18842497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenteric vasoconstriction triggers nitric oxide overproduction in the superior mesenteric artery of portal hypertensive rats.
    Tsai MH; Iwakiri Y; Cadelina G; Sessa WC; Groszmann RJ
    Gastroenterology; 2003 Nov; 125(5):1452-61. PubMed ID: 14598261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic inhibition of nitric oxide ameliorates splanchnic hyposensitivity to glypressin in a hemorrhage-transfused rat model of portal hypertension.
    Huang HC; Chu CJ; Lee FY; Chang FY; Wang SS; Lin HC; Hou MC; Chan CC; Wu SL; Chen CT; Lee SD
    Scand J Gastroenterol; 2000 Dec; 35(12):1308-13. PubMed ID: 11199372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thalidomide ameliorates portal hypertension via nitric oxide synthase independent reduced systolic blood pressure.
    Theodorakis NG; Wang YN; Korshunov VA; Maluccio MA; Skill NJ
    World J Gastroenterol; 2015 Apr; 21(14):4126-35. PubMed ID: 25892862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.